Trifluoroacetic acid → N-(2-{5-[4-(Benzothiazol-2-yloxy)-benzyl]-hexahydro-pyrrolo[3,4-b]pyrrol-1-yl}-2-oxo-ethyl)-2,2,2-trifluoro-acetamide

HRID 384527Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 384527
Cl.[NH:2]1[CH2:6][CH2:5][CH:4]2[CH2:7][N:8]([CH2:10][C:11]3[CH:26]=[CH:25][C:14]([O:15][C:16]4[S:17][C:18]5[CH:24]=[CH:23][CH:22]=[CH:21][C:19]=5[N:20]=4)=[CH:13][CH:12]=3)[CH2:9][CH:3]12.CCN(CC)CC.[C:34]([NH:41][CH2:42][C:43]([OH:45])=O)(OC(C)(C)C)=[O:35].Cl.CN(C)CCCN=C=NCC.[F:58][C:59]([F:64])([F:63])C(O)=O>C(Cl)Cl.CO.CS(C)=O>[S:17]1[C:18]2[CH:24]=[CH:23][CH:22]=[CH:21][C:19]=2[N:20]=[C:16]1[O:15][C:14]1[CH:25]=[CH:26][C:11]([CH2:10][N:8]2[CH2:7][CH:4]3[CH:3]([N:2]([C:43](=[O:45])[CH2:42][NH:41][C:34](=[O:35])[C:59]([F:64])([F:63])[F:58])[CH2:6][CH2:5]3)[CH2:9]2)=[CH:12][CH:13]=1

Komponenten

8

Edukt 5

HCID 6422Trifluoroacetic acidHCID 8471TriethylamineHCID 78288N-(tert-butoxycarbonyl)glycineHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 425990812-[4-(Hexahydro-pyrrolo[3,4-b]pyrrol-5-ylmethyl)-phenoxy]-benzothiazole hydrochloride

Produkt 1

HCID 42599593N-(2-{5-[4-(Benzothiazol-2-yloxy)-benzyl]-hexahydro-pyrrolo[3,4-b]pyrrol-1-yl}-2-oxo-ethyl)-2,2,2-trifluoro-acetamideAusbeute 20 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6344DichloromethaneLösungsmittelHCID 22036561Dimethyl sulfoxide methanolLösungsmittel

Versuchsvorschrift

To a stirred solution of 2-[4-(hexahydro-pyrrolo[3,4-b]pyrrol-5-ylmethyl)-phenoxy]-benzothiazole hydrochloride (100 mg, 0.26 mmol) and Et3N (215 μL, 1.6 mmol) in CH2Cl2 (2 mL) was added N-Boc-glycine (95 mg, 0.5 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (104 mg, 0.5 mmol). The resulting solution was then stirred at rt for 16 h. The resulting mixture was then treated with trifluoroacetic acid (1 mL) at rt for 3 h. The crude solid was dissolved in CH3OH/DMSO (2:1) and purified via reverse phase preparative HPLC to yield the title compound as a fluffy white solid (26 mg, 20%). MS (ESI): mass calcd. for C24H23F3N4O3S, 504.5; m/z found, 505.2 [M+H]+. 1H NMR (500 MHz, CDCl3): 7.74 (d, J=7.7 Hz, 1H), 7.68 (d, J=8.0 Hz, 1H), 7.56-7.49 (m, 1H), 7.42-7.26 (m, 6H), 4.55-4.45 (m, 1H), 4.17-3.87 (m, 2H), 3.67 (d, J=13.1 Hz, 1H), 3.60-3.38 (m, 3H), 3.09-2.81 (m, 2H), 2.78-2.54 (m, 2H), 2.52-2.35 (m, 1H), 2.20-2.06 (m, 1H), 2.02-1.87 (m, 1H).

Aufarbeitung

  1. custompurified via reverse phase preparative HPLC

Quellen und Nachweise

ORD-Eintrag
ord-adcd40d33c7a4b0b8527640bc9e09432
Quelldatensatz
uspto-grants-2013_02
Patentnummer
US08367719B2

Notizen zur Reaktion

Wird geladen…